Advertisement
ADVANCED SEARCH

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Palepu, A. Articles by Anis, A. H. Search for Related Content PubMed PubMed Citation Articles by Palepu, A. Articles by Anis, A. H. Related Collections Health Economics - see also Medicare Other emergency medicine HIV infection, AIDS Drug misuse

Hospital utilization and costs in a cohort of injection drug users

Anita Palepu^*, Mark W. Tyndall, Hector Leon^¶, Jennifer Muller^*, Michael V. O'Shaughnessy^¶**, Martin T. Schechter^* and Aslam H. Anis^¶

From *the Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, the Department of Medicine, St. Paul's Hospital and the University of British Columbia, the British Columbia Centre for Excellence in HIV/AIDS, the Department of Health Care and Epidemiology, University of British Columbia, ¶the Pharmacoeconomic Program, St. Paul's Hospital, and **the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC

Correspondence to: Dr. Anita Palepu, Rm. 620B, St. Paul's Hospital, 1081 Burrard St., Vancouver BC V6Z 1Y6; fax 604 806-8005; anita{at}hivnet.ubc.ca

Background: Many injection drug users (IDUs) seek care at emergency departments and some require hospital admission because of late presentation in the course of their illness. We determined the predictors of frequent emergency department visits and hospital admissions among community-based IDUs and estimated the incremental hospital utilization costs incurred by IDUs with early HIV infection relative to costs incurred by HIV-negative IDUs.

Methods: The Vancouver Injection Drug User Study (VIDUS) is a prospective cohort study involving IDUs that began in 1996. Our analyses were restricted to the 598 participants who gave informed consent for our study. We used the participants' responses to the baseline VIDUS questionnaire and, from medical records at St. Paul's Hospital, Vancouver, we collected detailed information about the frequency of emergency department visits, hospital admissions and the primary diagnosis for all visits or hospital stays between May 1, 1996, and Aug. 31, 1999. The incremental difference in hospital utilization costs by HIV status was estimated, based on 105 admissions in a subgroup of 64 participants.

Results: A total of 440 (73.6%) of the 598 IDUs made 2763 visits to the emergency department at St. Paul's Hospital during the study period. Of these 440, 265 (60.2%) made frequent visits (3 or more). The following factors were associated with frequent use: HIV-positive status (seroprevalent: adjusted odds ratio [OR] 1.7, 95% confidence interval [CI] 1.2–2.6; seroconverted during study period: adjusted OR 3.0, 95% CI 1.6–5.7); more than 4 injections daily (adjusted OR 1.5, 95% CI 1.1–2.1); cocaine use more frequent than use of other drugs (adjusted OR 2.0, 95% CI 1.2–3.6); and unstable housing (adjusted OR 1.5, 95% CI 1.1–2.2). During the study period 210 of the participants were admitted to hospital 495 times; 118 (56.2%) of them were admitted frequently (2 or more admissions). The 2 most common reasons for admission were pneumonia (132 admissions among 79 patients) and soft-tissue infections (cellulitis and skin abscess) (90 admissions among 59 patients). The following factors were independently associated with frequent hospital admissions: HIV-positive status (seroprevalent: adjusted OR 5.4, 95% CI 3.4–8.6; seroconverted during study period: adjusted OR 2.9, 95% CI 1.4–6.0); and female sex (adjusted OR 1.8, 95% CI 1.1–3.1). The incremental hospital utilization costs incurred by HIV-positive IDUs relative to the costs incurred by HIV-negative IDUs were $1752 per year.

Interpretation: Hospital utilization was significantly higher among community-based IDUs with early HIV disease than among those who were HIV negative. Much of the hospital use was related to complications of injection drug use and may be reduced with the establishment of programs that integrate harm reduction strategies with primary care and addiction treatment.

This article has been cited by other articles:

				A. Nyamathi, P. Compton, A. Cohen, M. Marfisee, S. Shoptaw, B. Greengold, V. de Castro, M. Reaves, A. Hasson, D. George, et al. Correlates of Hospitalization for Alcohol-Using Methadone-Maintained Persons With Physical Health Problems West J Nurs Res, June 1, 2009; 31(4): 525 - 543. [Abstract] [PDF]

				G. N. Al-Rawahi, A. G. Schreader, S. D. Porter, D. L. Roscoe, R. Gustafson, and E. A. Bryce Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later J. Clin. Microbiol., February 1, 2008; 46(2): 477 - 479. [Abstract] [Full Text] [PDF]

				J.-A. Stoltz, E. Wood, W. Small, K. Li, M. Tyndall, J. Montaner, and T. Kerr Changes in injecting practices associated with the use of a medically supervised safer injection facility J Public Health, March 1, 2007; 29(1): 35 - 39. [Abstract] [Full Text] [PDF]

				M. Gilbert, J. MacDonald, D. Gregson, J. Siushansian, K. Zhang, S. Elsayed, K. Laupland, T. Louie, K. Hope, M. Mulvey, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration Can. Med. Assoc. J., July 18, 2006; 175(2): 149 - 154. [Abstract] [Full Text] [PDF]

				R. J. Gordon and F. D. Lowy Bacterial infections in drug users. N. Engl. J. Med., November 3, 2005; 353(18): 1945 - 1954. [Full Text] [PDF]

				E. Wood, K. Li, C. L Miller, R. S Hogg, J. S G Montaner, M. T Schechter, and T. Kerr Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users Int. J. Epidemiol., February 1, 2005; 34(1): 152 - 158. [Abstract] [Full Text] [PDF]

				E. Wood, P. M. Spittal, W. Small, T. Kerr, K. Li, R. S. Hogg, M. W. Tyndall, J. S.G. Montaner, and M. T. Schechter Displacement of Canada's largest public illicit drug market in response to a police crackdown Can. Med. Assoc. J., May 11, 2004; 170(10): 1551 - 1556. [Abstract] [Full Text] [PDF]

				T. Kerr, E. Wood, D. Small, A. Palepu, and M. W. Tyndall Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside Can. Med. Assoc. J., October 14, 2003; 169(8): 759 - 763. [Abstract] [Full Text]

				P. M. Spittal, K. J.P. Craib, E. Wood, N. Laliberte, K. Li, M. W. Tyndall, M. V. O'Shaughnessy, and M. T. Schechter Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver Can. Med. Assoc. J., April 1, 2002; 166(7): 894 - 899. [Abstract] [Full Text] [PDF]

				E. Wood, M. W. Tyndall, T. Kerr, P. M. Spittal, M. V. O'Shaughnessy, and M. T. Schechter Safer injection facilities for injection drug users: the debate continues Can. Med. Assoc. J., February 1, 2002; 166(4): 422 - 422. [Full Text] [PDF]

				Harm reduction: closing the distance: Can. Med. Assoc. J., August 1, 2001; 165(4): 389 - 389. [Full Text] [PDF]

				La reduction des dommages : refermer l'ecart Can. Med. Assoc. J., August 1, 2001; 165(4): 391 - 391. [Full Text] [PDF]

				T. Kerr and A. Palepu Safe injection facilities in Canada: Is it time? Can. Med. Assoc. J., August 1, 2001; 165(4): 436 - 437. [Full Text] [PDF]

HOME	CURRENT ISSUE	PAST ISSUES	COLLECTIONS	HELP	SEARCH
Copyright 1995-2001, Canadian Medical Association. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p) All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.